Clinical trial
Botulinum Toxin Type A (Botox) for the Treatment of Cervical Dystonia and Upper…
NCT00178945 · Vanderbilt University, Other · Completed
Key facts
| NCT number | NCT00178945 |
|---|---|
| Title | Botulinum Toxin Type A (Botox) for the Treatment of Cervical Dystonia and Upper Thoracic Muscular Pain |
| Official title | Randomized, Double-Blind, Placebo-Controlled, Crossover Study of Botulinum Toxin Type A (Botox) for the Treatment of Pain Associated With Cervical Dystonia and Refractory Cervicothoracic Myofascial Pain Syndrome |
| Lead sponsor | Vanderbilt University, Other |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Refractory Cervicothoracic Myofascial Pain Syndrome (CMPS), Cervical Dystonia |
| Intervention type | Drug |
| Interventions | Botulinum Toxin Type A |
| Enrollment | 20 |
| Start date | Mar 1, 2004 |
| Completion | Mar 1, 2006 |
| First posted | Sep 15, 2005 |
| Last update posted | Jun 1, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: